Proceedings of the National Academy of Sciences, Volume 122, Issue 11, March 2025.
SignificanceOur data demonstrate the absence of overt toxicity and the therapeutic efficacy of the specific SOS1 inhibitor BI-3406 when used as a single therapy agent or in combination with the specific KRASG12Dinhibitor MRTX1133…
Read More